Cardiovascular Outcomes with Sotagliflozin

To the Editor: In the SOLOIST-WHF trial (Effect of Sotagliflozin on Cardiovascular Events in Patients with Type 2 Diabetes Post Worsening Heart Failure), Bhatt et al. (Jan. 14 issue) 1 report that death from cardiovascular causes and hospitalizations and urgent visits for heart failure (the composit...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The New England journal of medicine Jg. 384; H. 15; S. 1470 - 1473
Hauptverfasser:	Baglioni, Piero, Marchand, Lucien, Villar, Emmanuel, Green, Lisa, Bhatt, Deepak L, Steg, P. Gabriel, Pitt, Bertram
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Massachusetts Medical Society 15.04.2021
Schlagworte:	Cardiovascular diseases Congestive heart failure Diabetes Diabetes mellitus (non-insulin dependent) Diabetic Ketoacidosis Glycosides Heart failure Humans Mortality Placebos Renal Insufficiency, Chronic
ISSN:	0028-4793, 1533-4406, 1533-4406
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!